Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab

Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab

Dissecting cellulitis of the scalp (DCS) is an uncommon inflammatory disease that often results in scarring alopecia. Numerous therapies have either proved ineffective or only temporarily effective in the management of this condition. Recent reports show adequate responses to tumor necrosis factor (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Puerto Rico health sciences journal 2015-06, Vol.34 (2), p.102-104
Hauptverfasser: Ma, Rullan, Jennifer M
Format: Artikel
Sprache:eng
Schlagworte:
Adalimumab
Adult
Anti-Inflammatory Agents - therapeutic use
Antibodies, Monoclonal, Humanized - therapeutic use
Cellulitis - drug therapy
Humans
Male
Remission Induction
Scalp Dermatoses - drug therapy
Skin Diseases, Genetic - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dissecting cellulitis of the scalp (DCS) is an uncommon inflammatory disease that often results in scarring alopecia. Numerous therapies have either proved ineffective or only temporarily effective in the management of this condition. Recent reports show adequate responses to tumor necrosis factor (TNF) inhibitors in cases of DCS. We report a case of severe recalcitrant DCS successfully treated with adalimumab.
ISSN:0738-0658